000			02336 a2200589 4500
005			20250514025348.0
264		0	_c20020417
008			200204s 0 0 eng d
022			_a0732-183X
024	7		_a10.1200/JCO.2002.20.6.1600 _2doi
040			_aNLM _beng _cNLM
100	1		_aRidolfi, Ruggero
245	0	0	_aCisplatin, dacarbazine with or without subcutaneous interleukin-2, and interferon alpha-2b in advanced melanoma outpatients: results from an Italian multicenter phase III randomized clinical trial. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cMar 2002
300			_a1600-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aCarmustine _xadministration & dosage
650	0	4	_aCisplatin _xadministration & dosage
650	0	4	_aDacarbazine _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xadministration & dosage
650	0	4	_aInterleukin-2 _xadministration & dosage
650	0	4	_aItaly
650	0	4	_aMale
650	0	4	_aMelanoma _xdrug therapy
650	0	4	_aMiddle Aged
650	0	4	_aOutpatients
650	0	4	_aProportional Hazards Models
650	0	4	_aProspective Studies
650	0	4	_aQuality of Life
650	0	4	_aRecombinant Proteins
650	0	4	_aSkin Neoplasms _xdrug therapy
650	0	4	_aSurveys and Questionnaires
650	0	4	_aTreatment Outcome
700	1		_aChiarion-Sileni, Vanna
700	1		_aGuida, Michele
700	1		_aRomanini, Antonella
700	1		_aLabianca, Roberto
700	1		_aFreschi, Andrea
700	1		_aLo Re, Giovanni
700	1		_aNortilli, Rolando
700	1		_aBrugnara, Sonia
700	1		_aVitali, Patrizia
700	1		_aNanni, Oriana
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 20 _gno. 6 _gp. 1600-7
856	4	0	_uhttps://doi.org/10.1200/JCO.2002.20.6.1600 _zAvailable from publisher's website
999			_c11802292 _d11802292